China In Vitro Diagnostics Market is expected to grow over US$ 11 Billion by 2025; Finds New Report

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 - 2025.

The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.

“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 - 2025: Clinical Chemistry,Immunoassay,Molecular Testing,SMBG,Point of Care Testing (POCT), Hematology,Coagulation,Microbiology,Genetic Testing,Infectious Diagnostics,Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.

The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025.A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue.

The report also includes assessment of in vitro diagnostics regulation in China.Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers,restraints, trends and opportunities of the China in vitro diagnostics market.

Market Segmentation by Application and Analysis (2012 - 2025)

• Clinical Chemistry
• Immunoassay
• Molecular Testing
• Self–Monitoring of Blood Glucose (SMBG)
• Point of Care Testing (POCT)
• Hematology
• Coagulation
• Microbiology
• Genetic Testing
• Infectious Diagnostics
• Histology and Cytology

Spanning over 85 pages “China In Vitro Diagnostics Market Analysis 2012 - 2017 and Forecast 2018 - 2025” report covers Executive Summary, China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025), China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025), China In Vitro Diagnostics Market, Company Share by Revenue, 2017, China In Vitro Diagnostics Market Dynamics, China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025), China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017, Assessment of In Vitro Diagnostics Regulation in China, Major Partnership Deals in China In Vitro Diagnostics Market, Recent Developments in China In Vitro Diagnostics Market, Overview of Key Companies in China In Vitro Diagnostics Market. This report Covered Companies - Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Sysmex Corporation, Mindray Medical International Limited, Beckman Coulter Inc, Shanghai Fosun Pharmaceutical Group, Thermo Fisher Scientific Inc, Hologic Inc, Qiagen, Cepheid, Bio-Rad Laboratories Inc, Da An Gene Co. Ltd, Shanghai Kehua Bio–Engineering Co. Ltd..

Please visit this link for more details: http://mrr.cm/Uhm

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare